CA 19-9 test cost in Waterbury, CT — inpatient
In Waterbury, CT, 2 hospitals list a cash price for CA 19-9 blood test (tumor marker) as an inpatient: from $89.13 to $107.80, with a median of $98.47. The lowest listed price is at UConn Health, Waterbury Hospital — $9.34 less than the median here. Across Connecticut, the median is $83.07 at 14 hospitals.
Cash prices at 2 facilities for code 86301, as an inpatient (admitted to hospital) . Collected Sep 23, 2026; the hospital files themselves were last updated between Mar 31, 2026 and May 13, 2026.
Where each hospital's price falls
Each dot is one hospital's cash price on a scale from the lowest to the highest in Waterbury, CT.
Hospitals, cheapest first
| Hospital | Cash price | List price | Insurers pay | Off list | File date |
|---|---|---|---|---|---|
| UConn Health, Waterbury Hospital lowest Waterbury, CT · (203) 573-6000 CA 19-9 (SO) | $89.13 | $178.25 | — | 50% | May 13, 2026 source file |
| Saint Marys Hospital Waterbury, CT · (203) 709-6020 HC Immunoassay Tumor Antigen Quantitative Ca 19-9 | $107.80 | $196.00 | $18.55–$196.00 | 45% | Mar 31, 2026 source file |
| Saint Marys Hospital Waterbury, CT · (203) 709-6020 HC Warde Immunoassay Tumor Antigen Quantitative Ca 19-9 | $107.80 | $196.00 | $18.55–$196.00 | 45% | Mar 31, 2026 source file |
Inpatient: lowest $89.13, median $98.47, highest $107.80 — a 1.2× difference within the same market.
As an outpatient, the same code is billed by 2 facilities here, median $98.47 — that is the price to compare if you are not being admitted.
Cash or insurance?
At the one hospital here that publishes insurer rates for this code, the cash price is below the highest rate a health plan has negotiated. If you have insurance but have not met your deductible, you usually pay your plan's negotiated rate, which falls somewhere in the "Insurers pay" column. Paying cash can cost less, but a cash payment usually does not count toward your deductible. Ask the hospital for both numbers before you book.
What it is
CA 19-9 is a tumor marker used mainly to follow pancreatic and bile duct cancers during treatment.
What the price covers
The price usually covers running the test. The blood draw (36415) is often billed as a separate line.